These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

780 related items for PubMed ID: 8313549

  • 1. Exercise technetium-99m sestamibi tomography for cardiac risk stratification of patients with stable chest pain.
    Stratmann HG, Williams GA, Wittry MD, Chaitman BR, Miller DD.
    Circulation; 1994 Feb; 89(2):615-22. PubMed ID: 8313549
    [Abstract] [Full Text] [Related]

  • 2. Prognostic value of dipyridamole technetium-99m sestamibi myocardial tomography in patients with stable chest pain who are unable to exercise.
    Stratmann HG, Tamesis BR, Younis LT, Wittry MD, Miller DD.
    Am J Cardiol; 1994 Apr 01; 73(9):647-52. PubMed ID: 8166059
    [Abstract] [Full Text] [Related]

  • 3. Dipyridamole technetium-99m sestamibi myocardial tomography in patients evaluated for elective vascular surgery: prognostic value for perioperative and late cardiac events.
    Stratmann HG, Younis LT, Wittry MD, Amato M, Miller DD.
    Am Heart J; 1996 May 01; 131(5):923-9. PubMed ID: 8615311
    [Abstract] [Full Text] [Related]

  • 4. Exercise technetium-99m myocardial tomography for the risk stratification of men with medically treated unstable angina pectoris.
    Stratmann HG, Younis LT, Wittry MD, Amato M, Miller DD.
    Am J Cardiol; 1995 Aug 01; 76(4):236-40. PubMed ID: 7618615
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of dobutamine-atropine stress technetium-99m sestamibi perfusion scintigraphy in patients with chest pain.
    Geleijnse ML, Elhendy A, van Domburg RT, Cornel JH, Reijs AE, Roelandt JR, Krenning EP, Fioretti PM.
    J Am Coll Cardiol; 1996 Aug 01; 28(2):447-54. PubMed ID: 8800124
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Eleven-year prognostic value of dobutamine stress (99m)Tc-sestamibi myocardial perfusion imaging in patients with limited exercise capacity.
    Boiten HJ, van Domburg RT, Valkema R, Schinkel AF.
    Am J Cardiol; 2015 Apr 01; 115(7):884-9. PubMed ID: 25661571
    [Abstract] [Full Text] [Related]

  • 10. Dipyridamole technetium 99m sestamibi myocardial tomography as an independent predictor of cardiac event-free survival after acute ischemic events.
    Miller DD, Stratmann HG, Shaw L, Tamesis BR, Wittry MD, Younis LT, Chaitman BR.
    J Nucl Cardiol; 1994 Apr 01; 1(1):72-82. PubMed ID: 9420673
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Technetium-99m sestamibi myocardial perfusion imaging in the emergency room evaluation of chest pain.
    Hilton TC, Thompson RC, Williams HJ, Saylors R, Fulmer H, Stowers SA.
    J Am Coll Cardiol; 1994 Apr 01; 23(5):1016-22. PubMed ID: 8144763
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Incremental value of exercise technetium-99m tetrofosmin myocardial perfusion single-photon emission computed tomography for the prediction of cardiac events.
    Schinkel AF, Elhendy A, van Domburg RT, Bax JJ, Vourvouri EC, Bountioukos M, Rizzello V, Agricola E, Valkema R, Roelandt JR, Poldermans D.
    Am J Cardiol; 2003 Feb 15; 91(4):408-11. PubMed ID: 12586253
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dipyridamole technetium 99m sestamibi myocardial tomography for preoperative cardiac risk stratification before major or minor nonvascular surgery.
    Stratmann HG, Younis LT, Wittry MD, Amato M, Mark AL, Miller DD.
    Am Heart J; 1996 Sep 15; 132(3):536-41. PubMed ID: 8800022
    [Abstract] [Full Text] [Related]

  • 18. Myocardial technetium-99m sestamibi single-photon emission tomography as a prognostic tool in coronary artery disease: multivariate analysis in a long-term prospective study.
    Zanco P, Zampiero A, Favero A, Borsato N, Chierichetti F, Rubello D, Saitta B, Ferlin G.
    Eur J Nucl Med; 1995 Sep 15; 22(9):1023-8. PubMed ID: 7588939
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography.
    Berman DS, Hachamovitch R, Kiat H, Cohen I, Cabico JA, Wang FP, Friedman JD, Germano G, Van Train K, Diamond GA.
    J Am Coll Cardiol; 1995 Sep 15; 26(3):639-47. PubMed ID: 7642853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.